As of June 24, 2025, Tetra Bio Pharma Inc (TBP.TO) reports a Current Ratio of 0.81.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Tetra Bio Pharma Inc's Current Ratio
Over recent years, Tetra Bio Pharma Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2021-11-30 | 0.81 |
| 2020-11-30 | 0.53 |
| 2019-11-30 | 1.37 |
| 2018-11-30 | 5.72 |
| 2017-11-30 | 4.98 |
This slight downward trend highlights how Tetra Bio Pharma Inc manages its short-term assets and liabilities over time.
Comparing Tetra Bio Pharma Inc's Current Ratio to Peers
To better understand Tetra Bio Pharma Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Tetra Bio Pharma Inc (TBP.TO) | 0.81 |
| Titan Pharmaceuticals Inc (TTNP) | 6.08 |
| Skye Life Ventures Ltd (SKLV) | 4.98 |
| 48North Cannabis Corp (NRTH.V) | 3.96 |
| Khiron Life Sciences Corp (KHRN.V) | 3.08 |
| FSD Pharma Inc (HUGE.CN) | 2.28 |
Compared to its competitors, Tetra Bio Pharma Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.